Dynamics of hepatitis C virus quasispecies turnover during interferon alfa treatment
β Scribed by M. von Wagner; J.-H. Lee; B. Ruester; B. Kronenberger; C. Sarrazin; W.K. Roth; S. Zeuzem
- Book ID
- 118566069
- Publisher
- Elsevier Science
- Year
- 2003
- Tongue
- English
- Weight
- 120 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0168-8278
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
recently published data on human immunodeficiency vi-In about 30% to 40% of patients with chronic hepatitis rus type 1 (HIV-1) suggesting that both RNA viruses rep-C, treatment with recombinant interferon alfa (r-IFNa) licate continuously and highly productive in vivo. The causes a decrease of serum
Treatment of patients with chronic hepatitis C with recombinant interferon alfa (rIFN-alpha) can cause a decrease of serum transaminases and hepatitis C virus (HCV) RNA. Recent trials evaluating combination therapy of IFN-alpha and ribavirin suggested a potential synergistic effect. From serial meas